Search for European Projects

16 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Signalling compartmentalization and vesicle Trafficking at the Phagocytic Synapses (STEPS)

Start date: Apr 1, 2013, End date: Mar 31, 2019,

A key feature of the immune response is its specificity and macrophages must be able to discriminate precisely between an infectious stimulus and a non-infectious one and tune their response in accordance with the molecular context in which the target particle is recognized. In recent years, scientists have proposed the concept of the phagocytic synapse, to stress the fact that a particle does not ...
Read Project

 2

 FINISHED 

Epigenetics and microRNAs in Myocardial Function and Disease (CARDIOEPIGEN)

Start date: Oct 1, 2012, End date: Sep 30, 2018,

Heart failure (HF) is the ultimate outcome of many cardiovascular diseases. Re-expression of fetal genes in the adult heart contributes to development of HF. Two mechanisms involved in the control of gene expression are epigenetics and microRNAs (miRs). We propose a project on epigenetic and miR-mediated mechanisms leading to HF.Epigenetics refers to heritable modification of DNA and histones that ...
Read Project

 1

 FINISHED 

MEsenchymal stem cells to Reduce Liver INflammation (MERLIN)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

"Prevalence of liver disease is c6% (29 million people) in the EU with mortality rates from chronic liver diseases estimated at 14.3 per 100.000 in the EU-25 in 2004. Most liver diseases have a significant inflammatory component that underpins liver damage and fibrogenesis, yet current therapies have limited effectiveness. Safe novel anti-inflammatory therapies would satisfy a large unmet need for ...
Read Project

 9

 FINISHED 

Advanced Immunization Technologies (ADITEC)

Start date: Oct 1, 2011, End date: Sep 30, 2017,

Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to achieve what was previously deemed impossible. The scope of this project is to produce knowledge necessary to develop novel and ...
Read Project

 53

 FINISHED 

BeTheCuRE (BTCURE)

Start date: Apr 1, 2011, End date: Mar 31, 2017,

BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal models have to develop the line with the different subsets of the human diseases in order to be optimally used for drug discovery and drug evaluation. Our aim is to develop an understanding of the early process in human arthritis subsets and the animal models that ...
Read Project

 41

 FINISHED 

mRNA translational regulation in heart failure (MRNA IN HEART)

Start date: Apr 1, 2014, End date: Aug 29, 2016,

Protein synthesis is among the principal biological processes underlying cardiac hypertrophy, an early event in many forms of heart failure (HF). It is associated with worsening of cardiac function after long-term exposure to noxae. The rate-limiting step of protein synthesis is mRNA translation, which is controlled by factors involved in initiation and/or elongation. 4E-BPs regulate the translati ...
Read Project

 1

 FINISHED 

Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells (STEMIMMUNE)

Start date: Aug 1, 2012, End date: Jul 31, 2016,

"Here we seek to identify the genetic program at the basis of T memory stem cell persistence in vivo and use their properties to improve the adoptive T cell transfer for the treatment of human cancer. Adoptive cell transfer with tumour-specific T lymphocytes is currently under test in the clinic for the treatment of solid tumours such as melanoma. However, the poor persistence in vivo of adoptivel ...
Read Project

 1

 FINISHED 

TargetIng novel MEchanisms of Resolution in inflammation (TIMER)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The general objective of the TIMER Consortium is to identify and validate new molecules involved in the resolution of inflammation as a basis for the development of innovative therapeutic strategies in chronic inflammatory and autoimmune diseases. The project will invo ...
Read Project

 13

 FINISHED 

ICT-enabled, cellular artificial liver system incorporating personalized patient management and support (d-LIVER)

Start date: Oct 1, 2011, End date: Sep 30, 2015,

d-LIVER applies scenario-driven development methodologies to address an unmet need for bio-artificial liver support via continuous detoxification as remote transient therapy at the Point-of-Need. The liver is a complex organ with various vital functions in synthesis, detoxification and regulation; its failure is life-threatening and the only curative treatment is transplantation. Whilst awaiting t ...
Read Project

 15

 FINISHED 

Role of microRNAs 143 and 145 in cardiovascular physiology and disease: from bench to bedside (From Bench to Bedside)

Start date: Aug 1, 2011, End date: Jul 31, 2015,

Cardiometabolic diseases (CMD) (such as atherosclerosis, hypertension) are the primary cause of death and disability in the Western world. Although lifestyle programmes and therapeutic approaches have significantly reduced the socio-economic burden of CMD, a large number of events still cannot be avoided (residual risk). Neointimal hyperplasia is the principal pathogenic occurrence underlying athe ...
Read Project

 2

 FINISHED 

Global microRNA profiling of normal and Pbx1-null hematopoietic stem cells and progenitors for the identification of new regulators of the balance between self-renewal and differentiation (HSC self-renewal)

Start date: Aug 1, 2010, End date: Mar 18, 2015,

MicroRNAs (miRNAs) are non-coding RNA molecules that repress translation and stability of target mRNAs. They are key regulators of cell cycle and differentiation in embryonic stem cells, and are differentially expressed among many tumors, but their function in adult stem cells (SC) is not known. Somatic SC are able to self-renew, at the same time generating a differentiated progeny that replenish ...
Read Project

 1

 FINISHED 

Characterization of NK cell distributions and functions in human tissues in HIV-1 pathogenesis (CNKHIV)

Start date: Feb 1, 2011, End date: Jan 31, 2015,

"HIV is an urgent global health problem and a safe and effective vaccine is desperately required. Although many studies have shown that the innate immune system, and in particular, natural killer (NK) cells play a central role in determining the quality of the host immune response to HIV -1, the full host beneficial potential of the anti-HIV-1 NK-mediated activity can not be realized in vivo, as N ...
Read Project

 1

 FINISHED 

A Coordinated and Structured International Post-Doctoral Program to Foster Trans-national Mobility and Independent Career of Scientists in Biomedicine (SIPOD)

Start date: Mar 16, 2009, End date: Sep 15, 2014,

"This program encompasses the coordinated action of three major Biomedicine Research Centers and a Biotech shell in Lombardy, to launch a new Structured International Post-Doctoral program (SIPOD). These research centers operate in conjunction with the Scuola Europea di Medicina Molecolare (SEMM) whose aim is to promote the training and research of young scientists within emerging sectors of biome ...
Read Project

 4

 FINISHED 

The humoral innate immune system: long pentraxins as a paradigm (HIIS)

Start date: Jun 1, 2009, End date: May 31, 2014,

"The innate immune system consists of humoral and a cellular arm, but attention has largely been focused on cells and their receptors. The humoral innate immune system (HIIS) is generally represented as a collection of diverse molecules (collectins, ficolins, pentraxins). A tenet underlying this application is that in spite of molecular diversity, the HIIS is built on general principles and logic ...
Read Project

 1

 FINISHED 

Systems Biology of T-cell Activation in Health and Disease (SYBILLA)

Start date: Apr 1, 2008, End date: Sep 30, 2013,

T-cell activation, whether induced by pathogens or auto-antigens, is a complex process relying on multiple layers of tightly controlled intracellular signalling modules that form an intricate network. Defects in this network can cause severe and chronic disorders such as autoimmune diseases. Although 5% of the population suffer from these diseases, only a few therapeutic treatments are available. ...
Read Project

 22

 FINISHED 

Normalisation of immune reactivity in old age – from basic mechanisms to clinical application (TOLERAGE)

Start date: Apr 1, 2008, End date: Sep 30, 2012,

"When restoration of the immune response in older age is the target of basic and clinical research, boosting innate and adaptive immunity, e.g. by more efficient vaccination strategies, is the general approach. However, TOLERAGE has a fundamentally different focus, i.e. restoring the age-dependent decline of auto-tolerance that underlies the development of the paradigmatic age-associated diseases ...
Read Project

 10